License Option AgreementLicense Option Agreement • May 16th, 2016 • Immune Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMay 16th, 2016 Company IndustryThis Agreement made this day of May 15, 2016 by and between Immune Pharmaceuticals Inc. (“Immune”) with a principal place of business at 430 East 29th Street, Suite 940, New York, NY 10016 and Novel Pain Therapeutics LLC (“NPT”), a newly formed limited liability company with an office at 52 East End Avenue #12A New York, NY 10028